RE: New US Deal15 Dec 2021 12:40
Remember we are expecting another RNS on other U.K. approvals re “ As announced on 2 November 2021, the Company submitted 11 products for review under the CTDA to meet the original submission deadline of 1 September 2021. Further to the validation of its genesig® COVID-19 test, Novacyt's Primerdesign Ltd PROmate® COVID-19 test (encompassing both the PROmate® 1 Gene q16 and q32 products) remains on the temporary protocol and continues to be supplied to the NHS under the PHE National Microbiology Framework” but why keep quiet about sales & new partnerships outside U.K. ….. a lot of news to come I think